AUPH - Aurinia Pharmaceuticals Inc. (AUPH) CEO Peter Greenleaf on Q1 2020 Results - Earnings Call Transcript
Aurinia Pharmaceuticals, Inc. (AUPH)
Q1 2020 Earnings Conference Call
May 14, 2020, 16:30 ET
Company Participants
Glenn Schulman - SVP, Corporate Communications & IR
Peter Greenleaf - President, CEO & Director
Neil Solomons - Chief Medical Officer
Max Colao - Chief Commercial Officer
Joseph Miller - CFO
Michael Martin - Co-Founder & COO
Conference Call Participants
Alethia Young - Cantor Fitzgerald & Co.
Kenneth Cacciatore - Cowen and Company
Joseph Schwartz - SVB Leerink
Justin Kim - Oppenheimer
Antonio Arce - H.C. Wainwright & Co.
Maurice Raycroft - Jefferies
Tom Bishop - BI Research
Presentation